What Emergencies Happen in Dental Offices And How To Prevent Them

 

Visits to the dentist’s office are already stressful enough, without considering the emergencies that can and do happen in routine dental procedures. Allergic reactions, fainting, asthma attacks, and even heart attacks are not entirely uncommon, explains guest Damon Matlon, Product Manager for HealthFirst. Marketscale’s Healthcare Podcast explores how dental offices prepare for these emergencies with guest Matlon. The consequences of having unprepared emergency kits can be grave, but Matlon divulges a simple solution to the problem.

What’s more, the annual one-time fee includes free online courses and trainings on their medical kits, eligible for CE credits. The course covers administering the medications in the kit, including emergency oxygen. Other courses, like bloodborne pathogens training, the blood born pathogen, keep office staff learned in on top of mandatory skills and knowledge.

Dental offices can take this task off their plate with the aid of HealthFirst’s Practice Partner Program. With just one flat yearly fee, HealthFirst provides up-to-date medical kits to dental offices all over the country. HealthFirst tracks and replenishes these drugs, staying atop recalls and expirations and sourcing drugs from safe suppliers in the pharmaceutical supply chain.

What’s more, the one-time fee includes free online courses and trainings on their medical kits, eligible for CE credits. The course covers administering the medications in the kit, including emergency oxygen. Other courses, like the blood born pathogen, keep office staff learned in mandatory skills and knowledge.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Recent Episodes

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…